US · Healthcare · Diagnostics & Research
EPS came in at 0.32 against a street estimate of 0.16 — a beat of 100.0%.
Analysts rate BillionToOne, Inc. Class A Common Stock a strong buy (7 buy, 1 hold, 0 sell out of 8) with an average price target of $129.00.
| Fund | Stake |
|---|---|
| Adams Street Partners LLC | 3.63% |
| T. Rowe Price Associates, Inc. | 2.14% |
| Baillie Gifford & Co Limited. | 1.91% |
| Vanguard Portfolio Management, LLC | 1.78% |
| Amvescap Plc. | 1.77% |
| Vanguard Capital Management, LLC | 1.69% |
| Neuberger Berman Group LLC | 1.62% |
| BAMCO Inc | 1.57% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $122,981, compared with $83,523 in the third quarter of 2025. • Nine-month 2026 revenue was $340,8 | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $123.0 million, up 47% from $83.5 million in the third quarter of 2025. • Net income attributable | 2026-11-04 |
| Quarterly report · Q2 2026 BILLIONONE, INC. - Q2 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q2 2026: $109.4 million (vs. $66.6 million in Q2 2025, +64% growth) • Revenu | 2026-08-05 |
| Results announced · Q3 2026 BILLIONTOONE Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 total revenue: $109.4 million (vs. $66.6 million in Q2 2025), representing 64% year | 2026-08-05 |
| Material agreement · Q2 2026 BILLIONTOONE, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • New facility lease: 62,659 square feet of office and laboratory space in Union City, CA • T | 2026-06-29 |
| Material agreement · Q2 2026 BILLIONTOONE, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Outstanding shares as of April 17, 2026 record date: 41,442,114 Class A common shares and 4 | 2026-06-16 |
| Quarterly report · Q1 2026 BILLIONONE, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $108.4 million vs. $59.0 million Q1 2025 (83.8% increase year-over-year) | 2026-05-06 |
| Results announced · Q2 2026 BILLIONTOONE Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue $108.4 million in Q1 2026, up 84% from $59.0 million in Q1 2025 • Prenatal cl | 2026-05-06 |
Readable in the app.
| Announcement | Date |
|---|---|
| Lease 62,659 sq ft facility to triple oncology lab capacity BillionToOne, a medical diagnostics company, signed a 12-year lease for approximately 62,659 square feet of office and laboratory space in Union City, California, starting August 2027. This | 2026-06-29 |
| Reiterates 2025 guidance and initiates full year 2026 guidance BillionToOne, Inc. issued an 8-K filing on January 12, 2026, announcing that it reiterated its full-year 2025 guidance and initiated new guidance for full-year 2026. The company made these a | 2026-01-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BillionToOne, Inc. Class A Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.